Mairs & Power Inc Pfizer Inc Transaction History

Mairs & Power Inc

$10.3 Billion
Q2 2024

A detailed history of Mairs & Power Inc transactions in Pfizer Inc stock. As of the latest transaction made, Mairs & Power Inc holds 111,735 shares of PFE stock, worth $3.32 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

111,735

Previous 135,390 17.47%

Holding current value

$3.32 Million

Previous $3.76 Million 16.8%

% of portfolio

0.03%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $597,525 - $700,188	-23,655 Reduced 17.47%	111,735 $3.13 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $1.02 Million - $1.18 Million	-39,586 Reduced 22.62%	135,390 $3.76 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $2.16 Million - $2.8 Million	-82,576 Reduced 32.06%	174,976 $5.04 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $2.17 Million - $2.54 Million	-67,630 Reduced 20.8%	257,552 $8.54 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $1.65 Million - $1.91 Million	-45,648 Reduced 12.31%	325,182 $11.9 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $2.84 Million - $3.69 Million	-71,985 Reduced 16.26%	370,830 $15.1 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $1.18 Million - $1.54 Million	-28,278 Reduced 6.0%	442,815 $22.7 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $1.51 Million - $1.84 Million	-34,395 Reduced 6.8%	471,093 $20.6 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $4.41 Million - $5.23 Million	-94,764 Reduced 15.79%	505,488 $26.5 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $6.91 Million - $8.56 Million	-151,046 Reduced 20.1%	600,252 $31.1 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $36.5 Million - $54.2 Million	-884,335 Reduced 54.07%	751,298 $44.4 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $12.7 Million - $16.3 Million	-324,048 Reduced 16.54%	1,635,633 $70.3 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $1.82 Million - $2.06 Million	-50,736 Reduced 2.52%	1,959,681 $76.7 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $2.05 Million - $2.31 Million	-61,137 Reduced 2.95%	2,010,417 $72.8 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $6.6 Million - $8.39 Million	-197,088 Reduced 8.69%	2,071,554 $76.3 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $7.98 Million - $9.36 Million	-251,279 Reduced 9.97%	2,268,642 $83.3 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $7.04 Million - $8.54 Million	-233,610 Reduced 8.48%	2,519,921 $82.4 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $1.67 Million - $2.39 Million	-61,883 Reduced 2.2%	2,753,531 $89.9 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $40,425 - $45,878	-1,228 Reduced 0.04%	2,815,414 $110 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $14,523 - $18,832	447 Added 0.02%	2,816,642 $101 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $418,428 - $469,798	-11,315 Reduced 0.4%	2,816,195 $122 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $2.7 Million - $2.97 Million	-71,998 Reduced 2.48%	2,827,510 $120 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $22.1 Million - $25.2 Million	-573,950 Reduced 16.52%	2,899,508 $127 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $17.2 Million - $20.8 Million	-498,270 Reduced 12.55%	3,473,458 $153 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $8.42 Million - $8.98 Million	-255,342 Reduced 6.04%	3,971,728 $144 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $15.6 Million - $18.1 Million	-490,258 Reduced 10.39%	4,227,070 $150 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $1.64 Million - $1.74 Million	-49,443 Reduced 1.04%	4,717,328 $171 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $148 Million - $163 Million	4,766,771	4,766,771 $170 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mairs & Power Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mairs & Power Inc with notifications on news.

Account